Your browser doesn't support javascript.
loading
Periampullary tumors in a patient with pancreatic divisum and neurofibromatosis type 1: a case report.
Li, Bin-Bin; Zheng, Hui; Lou, Yi-Dan; Zhang, Wen-Wei; Zheng, Song.
Afiliação
  • Li BB; The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, 310053, Zhejiang, China.
  • Zheng H; Department of Medical Oncology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, 310000, Zhejiang, China.
  • Lou YD; Department of Medical Oncology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, 310000, Zhejiang, China.
  • Zhang WW; Department of Medical Oncology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, 310000, Zhejiang, China.
  • Zheng S; Zhejiang University School of Medicine, Hangzhou, China.
Hered Cancer Clin Pract ; 21(1): 18, 2023 Sep 29.
Article em En | MEDLINE | ID: mdl-37773168
INTRODUCTION: We present a case of a male patient with neurofibromatosis type 1 diagnosed with pancreatic divisum and several gastrointestinal tumors. A 55-year-old man was admitted to the hospital with recurrent chronic pancreatitis, indicating a large mass in the ampulla. In addition, genetic testing revealed two unique germline mutations in the neurofibromin (NF1) gene, and their potential interaction in promoting cancer was further investigated. CONCLUSION: The first similar case was reported in 2020. The current case was distinct from other cases since an additional two NF1 mutations were found in the patient. In conjunction with prior case reports, our findings imply that genetic testing in patients diagnosed with neurofibromatosis type 1 could be helpful in the development of effective treatments.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Hered Cancer Clin Pract Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Hered Cancer Clin Pract Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China